ADPOXIME-CV Dry Syrup

ADPOXIME-CV Dry Syrup is a broad-spectrum oral antibiotic combination containing Cefpodoxime Proxetil and Potassium Clavulanate, formulated for effective treatment of bacterial infections in pediatric patients. The combination enhances antibacterial activity by inhibiting beta-lactamase enzymes, thereby improving efficacy against resistant organisms. ADPOXIME-CV provides reliable coverage against common Gram-positive and Gram-negative pathogens.

Indications and Clinical Use

ADPOXIME-CV Dry Syrup is indicated for the treatment of:

• Upper respiratory tract infections (URTI)

• Lower respiratory tract infections (LRTI)

• Otitis media

• Tonsillitis and pharyngitis

• Sinusitis

• Urinary tract infections (UTIs)

• Skin and soft tissue infections

• Other susceptible bacterial infections as advised by the physician

Mechanism of Action

• Cefpodoxime Proxetil is a third-generation cephalosporin antibiotic that inhibits bacterial cell wall synthesis, leading to bacterial cell death.

• Potassium Clavulanate is a beta-lactamase inhibitor that protects Cefpodoxime from enzymatic degradation, thereby extending its antibacterial spectrum.

Together, they provide enhanced and sustained antibacterial action, especially against beta-lactamase-producing organisms.

Dosage and Administration

• Dosage: As directed by the physician.

• Reconstitute with boiled and cooled water up to the mark before use.

• Shake well before each dose.

• Dosage is based on the child’s age, body weight, and severity of infection.

• Complete the full course of therapy as prescribed.

Key Benefits of ADPOXIME-CV Dry Syrup

• Broad-spectrum antibacterial coverage

• Effective against resistant bacterial strains

• Suitable for pediatric use

• Well tolerated with good safety profile

• Convenient oral suspension formulation

Adverse Effects and Safety Information

ADPOXIME-CV Dry Syrup is generally well tolerated.

• Mild side effects may include diarrhea, nausea, vomiting, or abdominal discomfort.

• Hypersensitivity reactions such as rash may occur rarely.

• Discontinue use and consult a physician if severe adverse reactions develop.

Contraindications and Precautions

• Contraindicated in patients with known hypersensitivity to cephalosporins, penicillins, or beta-lactam antibiotics.

• Use with caution in patients with renal impairment or history of gastrointestinal disease.

• Use only under medical supervision.

Drug Interactions

• Concurrent use with anticoagulants may increase bleeding risk.

• Inform the physician about all ongoing medications before starting therapy.

Storage

• Store the dry powder in a cool, dry place, protected from light.

• After reconstitution, store as directed on the label and use within the specified period.

• Keep out of reach of children.